Bionformatics Resource Core
Bionformatics Resource Core
批准号:
10705728
负责人:
Katherine Phoenix Liao
金额:
$26.19万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2027-08-31
关键词:
AdultAreaAutomobile DrivingBioinformaticsChildhoodClinical DataClinical InvestigatorClinical ResearchCollaborationsCommunitiesComputerized Medical RecordConsultationsDataDevelopmentDisease OutcomeDisease modelEFRACEducationFacultyFeasibility StudiesFosteringFoundationsGrantInstitutionLearningMachine LearningMethodologyMethodsMissionMusculoskeletalMusculoskeletal DiseasesNational Institute of Arthritis, and Musculoskeletal, and Skin DiseasesNatural Language ProcessingPatient CarePatient-Focused OutcomesPhenotypePilot ProjectsPublishingResearchResearch PersonnelResourcesRheumatismRheumatologyServicesTechnologyWorkadvanced analyticsbioinformatics resourcecausal modeldata integrationdata sharingdesigndisorder riskexperiencefederated learninghealth equityinterestmedical schoolsprogramsresearch studysocial health determinantssupervised learningtooltreatment effectunsupervised learning
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
In this renewal, we build on our experience serving as the VERITY Bioinformatics Core, expanding Core
services to include advancements in the field since the last application. Research using electronic medical
record (EMR) data continues to grow with increasing availability of EMR data. Simultaneously, methods to
utilize data for research have also advanced including natural language processing (NLP) and machine
learning (ML) to extract crucial clinical data embedded in narrative notes, and to include these data in models
of disease risk and outcomes. However, there remains a large gap between access to raw EMR data
optimized for billing and patient care, and the ability to fully and appropriately utilize these data in clinical
research. Through consultations, courses offered as part of the Bioinformatics Core, and current Core projects,
we have identified 4 areas of high demand and/or unmet need for clinical investigators: (1) phenotyping using
EMR data; (2) extraction of clinical data from narrative notes using NLP, including early applications of this
technology to study social determinants of health; (3) use of EMR for studies of treatment effects and
applications of causal inference methods; and (4) approaches for multi-institutional EMR studies without
requiring direct sharing of data (termed federated learning).
The mission of the Bioinformatics Core remains supporting investigators from the pediatric and
adult rheumatic and musculoskeletal (MSK) research community to apply and integrate bioinformatics
approaches to clinical research studies using EMR data. While our target audience remains trainees and
junior faculty, in this renewal, our expanded services are also designed for established investigators interested
in incorporating bioinformatics to their research programs. Aim 1. To provide methods for investigators to
obtain robust and accurate phenotypes using information from EMRs and integrating these data for clinical
studies. This requires applying supervised and unsupervised machine learning approaches for phenotyping
with EMR data. As well, we will utilize causal inference methods applied to EMR data for studies of treatment
effects. Aim 2. To provide NLP support enabling clinical research studies with EMR data. We will support and
develop the use of NLP to incorporate social determinants of health (SDoH) in studies of health equity using
EMR data. As well, we will support and educate investigators on the use of NLP based data and tools. Aim 3.
To strengthen existing ties and build new partnerships between the rheumatic and MSK clinical research and
bioinformatics communities through Core platforms and consulting services.
The Bioinformatics Core team and a network of expert advisors will perform consultations, provide
educational services, and deliver bioinformatics research services to the Research Community. Additionally,
we will build on our foundation to enable cross-institutional studies with federated learning approaches for
clinical studies on rheumatic and musculoskeletal conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioinformatics Resource Core
-
批准号:10251979
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2017
-
负责人:Katherine Phoenix Liao
-
依托单位:
Bioinformatics Resource Core
-
批准号:10017674
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2017
-
负责人:Katherine Phoenix Liao
-
依托单位:
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
-
批准号:9883821
-
项目类别:
-
资助金额:$74.52万
-
财政年份:2016
-
负责人:Katherine Phoenix Liao
-
依托单位:
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
-
批准号:9028324
-
项目类别:
-
资助金额:$89.37万
-
财政年份:2016
-
负责人:Katherine Phoenix Liao
-
依托单位:
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
-
批准号:9247066
-
项目类别:
-
资助金额:$80.82万
-
财政年份:2016
-
负责人:Katherine Phoenix Liao
-
依托单位:
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
-
批准号:8493997
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Katherine Phoenix Liao
-
依托单位:
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
-
批准号:8300896
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Katherine Phoenix Liao
-
依托单位:
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
-
批准号:8687593
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Katherine Phoenix Liao
-
依托单位:
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
-
批准号:8878177
-
项目类别:
-
资助金额:$11.85万
-
财政年份:2011
-
负责人:Katherine Phoenix Liao
-
依托单位:
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
-
批准号:8190112
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Katherine Phoenix Liao
-
依托单位:
Bioinformatics Resource Core
-
批准号:9768195
-
项目类别:
-
资助金额:$21.61万
-
财政年份:--
-
负责人:Katherine Phoenix Liao
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: